Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Tretinoin and Liarozole

supplement:

Tretinoin

Research Papers that Mention the Interaction

Liarozole is an imidazole compound that inhibits enzymes involved in steroid hormone aromatisation and retinoid metabolism.
Breast Cancer Research and Treatment  •  2004  |  View Paper
On days 2 and 29, liarozole was given 1 h prior to ingestion of all-trans RA at single doses ranging from 75 to 300 mg.
We conclude that liarozole at a dose of 300 mg effectively attenuates the induced decline in all-trans RA plasma concentrations that occurs with continuous treatment.
Cancer Chemotherapy and Pharmacology  •  2004  |  View Paper
Liarozole is an imidazole‐like compound that inhibits the retinoic acid (RA) 4‐hydroxylase‐mediated breakdown of all‐trans RA, causing elevation of plasma and cutaneous levels of RA.
The British journal of dermatology  •  2001  |  View Paper
Liarozole is a 1-substituted imidazole derivative that inhibits cytochrome P450 activity and increases endogenous plasma concentrations of retinoid acid (RA).
Clinical cancer research : an official journal of the American Association for Cancer Research  •  2000  |  View Paper
Background Liarozole is an inhibitor of the metabolism of all‐trans‐retinoic acid.
The British journal of dermatology  •  2000  |  View Paper
Liarozole is a novel inhibitor of the enzyme cytochrome P450 which has inhibitory effects on the 4-hydroxylation of retinoic acid.
Skin pharmacology and applied skin physiology  •  1998  |  View Paper
Liarozole promotes differentiation of cancer cells by increasing the intratumoral levels of retinoic acid.
Urology  •  1998  |  View Paper
The imidazole derivative liarozole is a potent inhibitor of cytochrome P450‐dependent 4‐hydroxyla‐tion of endogenous all‐trans retinoic acid , thereby increasing the levels of all‐trans retinoic acid in both plasma and skin.
The British journal of dermatology  •  1998  |  View Paper
Liarozole is an imidazole derivative that has been identified as an inhibitor of the cytochrome P450‐dependent all‐trans retinoid acid (RA) breakdown.
The Prostate  •  1997  |  View Paper
Liarozole , a novel imidazole derivative, inhibits the cytochrome P450‐dependent 4‐hydroxylation of retinoic acid.
The British journal of dermatology  •  1997  |  View Paper
Show More